Regulation .04 Review of Prescription Monitoring Data.
Regulation .04 Review of Prescription Monitoring Data.LinkCopy Citation
A.
The Program shall review prescription monitoring data and naloxone medication data for indications of possible:
(1)
Misuse or abuse of a monitored prescription drug; and
(2)
Violations of law or possible breaches of professional standards by a prescriber or a dispenser.
B.
In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.